Literature DB >> 28653121

[Radiation with additional antiandrogen therapy in recurrent prostate cancer].

Stephan Roth1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28653121     DOI： 10.1007/s00066-017-1171-4

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  20 in total

1.  Long-term outcomes after high-dose postprostatectomy salvage radiation treatment.

Authors:  Anuj Goenka; Juan Martin Magsanoc; Xin Pei; Michael Schechter; Marisa Kollmeier; Brett Cox; Peter T Scardino; James A Eastham; Michael J Zelefsky
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-01-31       Impact factor: 7.038

2.  Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.

Authors:  William U Shipley; Wendy Seiferheld; Himanshu R Lukka; Pierre P Major; Niall M Heney; David J Grignon; Oliver Sartor; Maltibehn P Patel; Jean-Paul Bahary; Anthony L Zietman; Thomas M Pisansky; Kenneth L Zeitzer; Colleen A F Lawton; Felix Y Feng; Richard D Lovett; Alexander G Balogh; Luis Souhami; Seth A Rosenthal; Kevin J Kerlin; James J Dignam; Stephanie L Pugh; Howard M Sandler
Journal:  N Engl J Med       Date:  2017-02-02       Impact factor: 91.245

3.  A matched control analysis of adjuvant and salvage high-dose postoperative intensity-modulated radiotherapy for prostate cancer.

Authors:  Piet Ost; Bart De Troyer; Valérie Fonteyne; Willem Oosterlinck; Gert De Meerleer
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-08-01       Impact factor: 7.038

4.  Long-term results of adjuvant versus early salvage postprostatectomy radiation: A large single-institutional experience.

Authors:  Daniela L Buscariollo; Michael Drumm; Andrzej Niemierko; Rebecca H Clayman; Sigolene Galland-Girodet; Danielle Rodin; Adam S Feldman; Douglas M Dahl; Francis J McGovern; Aria F Olumi; Alec Eidelman; William U Shipley; Anthony L Zietman; Jason A Efstathiou
Journal:  Pract Radiat Oncol       Date:  2016-10-19

5.  Functional Outcomes and Quality of Life After Radical Prostatectomy Only Versus a Combination of Prostatectomy with Radiation and Hormonal Therapy.

Authors:  Meike Adam; Pierre Tennstedt; Dominik Lanwehr; Derya Tilki; Thomas Steuber; Burkhard Beyer; Imke Thederan; Hans Heinzer; Alexander Haese; Georg Salomon; Lars Budäus; Uwe Michl; Dirk Pehrke; Pär Stattin; Jürgen Bernard; Bernd Klaus; Raisa S Pompe; Cordula Petersen; Hartwig Huland; Markus Graefen; Rudolf Schwarz; Wolfgang Huber; Stacy Loeb; Thorsten Schlomm
Journal:  Eur Urol       Date:  2016-11-22       Impact factor: 20.096

6.  Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years.

Authors:  P Iversen; C J Tyrrell; A V Kaisary; J B Anderson; L Baert; T Tammela; M Chamberlain; K Carroll; K Gotting-Smith; G R Blackledge
Journal:  Urology       Date:  1998-03       Impact factor: 2.649

7.  Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis.

Authors:  Alberto Briganti; Thomas Wiegel; Steven Joniau; Cesare Cozzarini; Marco Bianchi; Maxine Sun; Bertrand Tombal; Karin Haustermans; Tom Budiharto; Wolfgang Hinkelbein; Nadia Di Muzio; Pierre I Karakiewicz; Francesco Montorsi; Hein Van Poppel
Journal:  Eur Urol       Date:  2012-05-16       Impact factor: 20.096

8.  Concurrent androgen deprivation therapy during salvage prostate radiotherapy improves treatment outcomes in high-risk patients.

Authors:  Daniel E Soto; Michael N Passarelli; Stephanie Daignault; Howard M Sandler
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-05-05       Impact factor: 7.038

9.  Impact of adjuvant radiotherapy on survival of patients with node-positive prostate cancer.

Authors:  Firas Abdollah; R Jeffrey Karnes; Nazareno Suardi; Cesare Cozzarini; Giorgio Gandaglia; Nicola Fossati; Damiano Vizziello; Maxine Sun; Pierre I Karakiewicz; Mani Menon; Francesco Montorsi; Alberto Briganti
Journal:  J Clin Oncol       Date:  2014-09-22       Impact factor: 44.544

10.  Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome--results of a retrospective study.

Authors:  Thomas Wiegel; Gunnar Lohm; Dirk Bottke; Stefan Höcht; Kurt Miller; Alessandra Siegmann; Martin Schostak; Konrad Neumann; Wolfgang Hinkelbein
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-10-27       Impact factor: 7.038
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.